Though intuitively, people should prefer a pill over an injection, in my experience, patients are willing to take the weekly injection if it provides more robust weight and A1C lowering outcomes, says Tan
22 Multi-purpose retailers are likely to be less impacted due to a typically diverse offering, while those with pharmacies could see higher sales and increased foot traffic through offering GLP-1RAs
People worry about their moles because they have heard about melanoma, a malignant proliferation of melanocytes that is the most common reason for death from skin cancer
Additionally, the delayed gastric emptying caused by GLP-1 medications may affect the absorption of some oral medicines, so follow product-specific guidance and consult your healthcare provider about potential interactions
For a broader look at how peptide therapy integrates with this clinical challenge, our post on peptides for fat loss during menopause and what the clinical evidence actually shows for women navigating midlife weight gain covers the full picture in detail
Key facts Pennsylvania Medicaid dropped GLP-1 obesity coverage effective January 1, 2026 UPMC Medicaid members no longer have a weight-loss Wegovy path through the plan, though the cardiovascular indication is retained